Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Multiple Sclerosis

  Free Subscription


08.03.2010

2 Acta Neurol Scand
2 Ann Neurol
1 Clin Exp Immunol
1 J Immunol
2 J Neuroimmunol
1 J Neurol
1 J Neurol Sci
1 Lancet
10 Mult Scler
9 Neurology
1 Neurosci Lett


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. VERBEEK MM , Lefeber DJ, Jongen PJ
    Chitotriosidase activity in controls and multiple sclerosis.
    Acta Neurol Scand. 2010.
    PubMed     Text format     Related articles   

  2. DETTMERS C , Sulzmann M, Ruchay-Plossl A, Gutler R, et al
    Endurance exercise improves walking distance in MS patients with fatigue.
    Acta Neurol Scand. 2009.
    PubMed     Text format     Related articles    Abstract available


    Ann Neurol

  3. SAWCER S , Ban M, Wason J, Dudbridge F, et al
    What role for genetics in the prediction of multiple sclerosis?
    Ann Neurol. 2010;67:3-10.
    PubMed     Text format     Related articles    Abstract available


  4. Experimental multiple sclerosis vascular shunting procedure halted at Stanford.
    Ann Neurol. 2010;67:A13-5.
    PubMed     Text format     Related articles   


    Clin Exp Immunol

  5. HARNETT MM , Melendez AJ, Harnett W
    The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.
    Clin Exp Immunol. 2010;159:256-67.
    PubMed     Text format     Related articles    Abstract available


    J Immunol

  6. NILAND B , Miklossy G, Banki K, Biddison WE, et al
    Cleavage of Transaldolase by Granzyme B Causes the Loss of Enzymatic Activity with Retention of Antigenicity for Multiple Sclerosis Patients.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available


    J Neuroimmunol

  7. ALDINUCCI A , Biagioli T, Manuelli C, Repice AM, et al
    Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP.
    J Neuroimmunol. 2010;218.
    PubMed     Text format     Related articles    Abstract available

  8. JURYNCZYK M , Selmaj K
    Notch: a new player in MS mechanisms.
    J Neuroimmunol. 2010;218.
    PubMed     Text format     Related articles    Abstract available


    J Neurol

  9. YALDIZLI O , Atefy R, Gass A, Sturm D, et al
    Corpus callosum index and long-term disability in multiple sclerosis patients.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available


    J Neurol Sci

  10. MEHTA BK
    New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


    Lancet

  11. BLACK S , Eskola J, Siegrist CA, Halsey N, et al
    Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.
    Lancet. 2009.
    PubMed     Text format     Related articles    Abstract available


    Mult Scler

  12. GONSETTE RE , Sindic C, D'hooghe MB, De Deyn PP, et al
    Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon {beta} in relapsing-remitting Multiple Sclerosis (ASIIMS) trial.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  13. DE STEFANO N , Curtin F, Stubinski B, Blevins G, et al
    Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  14. HAWKES CH , Giovannoni G
    The McDonald Criteria for Multiple Sclerosis: time for clarification.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  15. DIAZ-SANCHEZ M , Gomez-Moreno SM, Morales-Otal MA, Ramos-Gonzalez A, et al
    Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  16. STANKOVIC A , Dincic E, Ristic S, Lovrecic L, et al
    Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  17. POMEROY I , Jordan E, Frank J, Matthews P, et al
    Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  18. LAZZARINO G , Amorini A, Eikelenboom M, Killestein J, et al
    Cerebrospinal fluid ATP metabolites in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  19. DELOIRE M , Ruet A, Hamel D, Bonnet M, et al
    Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  20. JUNG K
    Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.
    Mult Scler. 2009;15:1372-3.
    PubMed     Text format     Related articles   

  21. CUTTER G
    Evidence of treatment benefit: is seeing believing or obfuscation by statistics?
    Mult Scler. 2009;15:1251-2.
    PubMed     Text format     Related articles   


    Neurology

  22. FOX RJ
    Primary neuroprotection. The Holy Grail of multiple sclerosis therapy.
    Neurology. 2010.
    PubMed     Text format     Related articles   

  23. BARKHOF F , Hulst HE, Drulovic J, Uitdehaag BM, et al
    Ibudilast in relapsing-remitting multiple sclerosis. A neuroprotectant?
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available

  24. ZELLER D , Aufm Kampe K, Biller A, Stefan K, et al
    Rapid-onset central motor plasticity in multiple sclerosis.
    Neurology. 2010;74:728-35.
    PubMed     Text format     Related articles    Abstract available

  25. LISAK RP , Korngold S
    Insights for practice: where mechanism of action meets patient management.
    Neurology. 2010;74 Suppl 1:S70-3.
    PubMed     Text format     Related articles   

  26. VOLLMER T , Stewart T, Baxter N
    Mitoxantrone and cytotoxic drugs' mechanisms of action.
    Neurology. 2010;74 Suppl 1:S41-6.
    PubMed     Text format     Related articles    Abstract available

  27. BIELEKOVA B , Becker BL
    Monoclonal antibodies in MS: mechanisms of action.
    Neurology. 2010;74 Suppl 1:S31-40.
    PubMed     Text format     Related articles    Abstract available

  28. CALABRESE M , Rinaldi F, Mattisi I, Grossi P, et al
    Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Neurology. 2010;74:321-8.
    PubMed     Text format     Related articles    Abstract available

  29. OKADA K , Matsushita T, Kira J, Tsuji S, et al
    B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
    Neurology. 2010;74:177-8.
    PubMed     Text format     Related articles   

  30. MONTALBAN X , Tintore M, Swanton J, Barkhof F, et al
    MRI criteria for MS in patients with clinically isolated syndromes.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available


    Neurosci Lett

  31. EWA P , Zbigniew S, Pawel G, Konrad R, et al
    CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients.
    Neurosci Lett. 2010.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.

   Design: